Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension

Journal of Physiology

Volumn 594, Issue 5, 2016, Pages 1167-1177

  Veith, Christine ^a   Schermuly, Ralph T ^a   Brandes, Ralf P ^b   Weissmann, Norbert ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; HYPOXIA INDUCIBLE FACTOR; MATRIX PROTEIN; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN;

BLOOD OXYGEN TENSION; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; GENE TARGETING; HUMAN; LUNG ARTERY PRESSURE; MOLECULAR DYNAMICS; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TARGETING; PULMONARY ARTERY; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SMOOTH MUSCLE CELL;

ANIMALS; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1; MYOCYTES, SMOOTH MUSCLE; OXYGEN;

EID: 84959302629     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270689     Document Type: Review

References (99)

1. Abud EM, Maylor J, Undem C, Punjabi A, Zaiman AL, Myers AC, Sylvester JT, Semenza GL & Shimoda LA (2012). Digoxin inhibits development of hypoxic pulmonary hypertension in mice. Proc Natl Acad Sci U S A 109, 1239-1244.
2. Ahn YT, Kim YM, Adams E, Lyu SC, Alvira CM & Cornfield DN (2012). Hypoxia-inducible factor-1α regulates KCNMB1 expression in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 302, L352-L359.
3. Arias-Stella J & Saldana M (1963). The terminal portion of the pulmonary arterial tree in people native to high altitudes. Circulation 28, 915-925.
4. Augstein A, Poitz DM, Braun-Dullaeus RC, Strasser RH & Schmeisser A (2011). Cell-specific and hypoxia-dependent regulation of human HIF-3α: inhibition of the expression of HIF target genes in vascular cells. Cell Mol Life Sci 68, 2627-2642.
5. Ball MK, Waypa GB, Mungai PT, Nielsen JM, Czech L, Dudley VJ, Beussink L, Dettman RW, Berkelhamer SK, Steinhorn RH, Shah SJ & Schumacker PT (2014). Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am J Respir Crit Care Med 189, 314-324.
6. Beckman JS & Koppenol WH (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 271, C1424-C1437.
7. Bland RD, Demling RH, Selinger SL & Staub NC (1977). Effects of alveolar hypoxia on lung fluid and protein transport in unanesthetized sheep. Circ Res 40, 269-274.
8. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Bonnet S, Haromy A, Harry G, Moudgil R, McMurtry MS, Weir EK & Archer SL (2006). An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 113, 2630-2641.
9. Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, Collen D & Carmeliet P (2003). Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 111, 1519-1527.
10. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC & Schumacker PT (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95, 11715-11720.
11. 2 sensing. J Biol Chem 275, 25130-25138.
12. Clerici C & Planes C (2009). Gene regulation in the adaptive process to hypoxia in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 296, L267-L274.
13. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, VanVeldhoven P, Plate K, Moons L, Collen D & Carmeliet P (2002). Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8, 702-710.
14. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ & Ratcliffe PJ (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
15. Esteve JM, Launay JM, Kellermann O & Maroteaux L (2007). Functions of serotonin in hypoxic pulmonary vascular remodeling. Cell Biochem Biophys 47, 33-44.
16. Fukuda R, Kelly B & Semenza GL (2003). Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res 63, 2330-2334.
17. Hagen T (2012). Oxygen versus reactive oxygen in the regulation of HIF-1α: the balance tips. Biochem Res Int 2012, 436981.
18. Hagen T, Taylor CT, Lam F & Moncada S (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302, 1975-1978.
19. Haugen M, Dammen R, Svejda B, Gustafsson BI, Pfragner R, Modlin I & Kidd M (2012). Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors. Am J Physiol Gastrointest Liver Physiol 303, G1164-G1173.
20. Heidbreder M, Frohlich F, Johren O, Dendorfer A, Qadri F & Dominiak P (2003). Hypoxia rapidly activates HIF-3α mRNA expression. FASEB J 17, 1541-1543.
21. Hickey MM, Richardson T, Wang T, Mosqueira M, Arguiri E, Yu H, Yu QC, Solomides CC, Morrisey EE, Khurana TS, Christofidou-Solomidou M & Simon MC (2010). The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J Clin Invest 120, 827-839.
22. Hislop A & Reid L (1976). New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 57, 542-554.
23. Howell K, Preston RJ & McLoughlin P (2003). Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 547, 133-145.
24. Huang LE, Arany Z, Livingston DM & Bunn HF (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem 271, 32253-32259.
25. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95, 7987-7992.
26. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM & Neckers L (2005). HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8, 143-153.
27. Ismail S, Sturrock A, Wu P, Cahill B, Norman K, Huecksteadt T, Sanders K, Kennedy T & Hoidal J (2009). NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-β1 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol 296, L489-L499.
28. 2 sensing. Science 292, 464-468.
29. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 12, 149-162.
30. Jeffery TK & Wanstall JC (2001). Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92, 1-20.
31. Jiang Y, Dai A, Li Q & Hu R (2007). Hypoxia induces transforming growth factor-β1 gene expression in the pulmonary artery of rats via hypoxia-inducible factor-1α. Acta Biochim Biophys Sin (Shanghai) 39, 73-80.
32. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA & Semenza GL (2003). Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93, 1074-1081.
33. Kim YM, Barnes EA, Alvira CM, Ying L, Reddy S & Cornfield DN (2013). Hypoxia-inducible factor-1α in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation. Circ Res 112, 1230-1233.
34. Klimova T & Chandel NS (2008). Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ 15, 660-666.
35. Kwapiszewska G, Wilhelm J, Wolff S, Laumanns I, Koenig IR, Ziegler A, Seeger W, Bohle RM, Weissmann N & Fink L (2005). Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir Res 6, 109.
36. Kwapiszewska G, Wygrecka M, Marsh LM, Schmitt S, Trosser R, Wilhelm J, Helmus K, Eul B, Zakrzewicz A, Ghofrani HA, Schermuly RT, Bohle RM, Grimminger F, Seeger W, Eickelberg O, Fink L & Weissmann N (2008). Fhl-1, a new key protein in pulmonary hypertension. Circulation 118, 1183-1194.
37. Laughner E, Taghavi P, Chiles K, Mahon PC & Semenza GL (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21, 3995-4004.
38. Lee K, Zhang H, Qian DZ, Rey S, Liu JO & Semenza GL (2009). Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proc Natl Acad Sci U S A 106, 17910-17915.
39. phox). Am J Physiol Lung Cell Mol Physiol 290, L2-L10.
40. Makino Y, Uenishi R, Okamoto K, Isoe T, Hosono O, Tanaka H, Kanopka A, Poellinger L, Haneda M & Morimoto C (2007). Transcriptional up-regulation of inhibitory PAS domain protein gene expression by hypoxia-inducible factor 1 (HIF-1): a negative feedback regulatory circuit in HIF-1-mediated signaling in hypoxic cells. J Biol Chem 282, 14073-14082.
41. Malczyk M, Veith C, Fuchs B, Hofmann K, Storch U, Schermuly RT, Witzenrath M, Ahlbrecht K, Fecher-Trost C, Flockerzi V, Ghofrani HA, Grimminger F, Seeger W, Gudermann T, Dietrich A & Weissmann N (2013). Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med 188, 1451-1459.
42. Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT & Simon MC (2005). Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab 1, 393-399.
43. Martin DS, Khosravi M, Grocott MP & Mythen MG (2010). Concepts in hypoxia reborn. Crit Care 14, 315.
44. Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B & Erzurum SC (2007). Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293, L548-L554.
45. Masson N, Singleton RS, Sekirnik R, Trudgian DC, Ambrose LJ, Miranda MX, Tian YM, Kessler BM, Schofield CJ & Ratcliffe PJ (2012). The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity. EMBO Rep 13, 251-257.
46. Maynard MA, Evans AJ, Hosomi T, Hara S, Jewett MA & Ohh M (2005). Human HIF-3α4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma. FASEB J 19, 1396-1406.
47. Milkiewicz M, Doyle JL, Fudalewski T, Ispanovic E, Aghasi M & Haas TL (2007). HIF-1α and HIF-2α play a central role in stretch-induced but not shear-stress-induced angiogenesis in rat skeletal muscle. J Physiol 583, 753-766.
48. Mittal M, Roth M, Konig P, Hofmann S, Dony E, Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA, Kwapiszewska G, Kummer W, Klepetko W, Hoda MA, Fink L, Hanze J, Seeger W, Grimminger F, Schmidt HH & Weissmann N (2007). Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 101, 258-267.
49. Mizuno S, Bogaard HJ, Kraskauskas D, Alhussaini A, Gomez-Arroyo J, Voelkel NF & Ishizaki T (2011). p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice. Am J Physiol Lung Cell Mol Physiol 300, L753-L761.
50. Nisbet RE, Graves AS, Kleinhenz DJ, Rupnow HL, Reed AL, Fan TH, Mitchell PO, Sutliff RL & Hart CM (2009). The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice. Am J Respir Cell Mol Biol 40, 601-609.
51. Nozik-Grayck E & Stenmark KR (2007). Role of reactive oxygen species in chronic hypoxia-induced pulmonary hypertension and vascular remodeling. Adv Exp Med Biol 618, 101-112.
52. Paddenberg R, Stieger P, von Lilien AL, Faulhammer P, Goldenberg A, Tillmanns HH, Kummer W & Braun-Dullaeus RC (2007). Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice. Resp Res 8, 15.
53. Page EL, Chan DA, Giaccia AJ, Levine M & Richard DE (2008). Hypoxia-inducible factor-1α stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell 19, 86-94.
54. Page EL, Robitaille GA, Pouyssegur J & Richard DE (2002). Induction of hypoxia-inducible factor-1α by transcriptional and translational mechanisms. J Biol Chem 277, 48403-48409.
55. Pak O, Aldashev A, Welsh D & Peacock A (2007). The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J 30, 364-372.
56. Partovian C, Adnot S, Raffestin B, Louzier V, Levame M, Mavier IM, Lemarchand P & Eddahibi S (2000). Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats. Am J Respir Cell Mol Biol 23, 762-771.
57. Prabhakar NR & Semenza GL (2012). Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 92, 967-1003.
58. + exchange and growth factors in pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 14, 139-145.
59. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS & Reid L (1979). Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol Heart Circ Physiol 236, H818-H827.
60. Sanders KA & Hoidal JR (2007). The NOX on pulmonary hypertension. Circ Res 101, 224-226.
61. Schroedl C, McClintock DS, Budinger GR & Chandel NS (2002). Hypoxic but not anoxic stabilization of HIF-1α requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 283, L922-L931.
62. Schultz K, Fanburg BL & Beasley D (2006). Hypoxia and hypoxia-inducible factor-1α promote growth factor-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 290, H2528-H2534.
63. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77-85.
64. Semenza GL (2000a). Expression of hypoxia-inducible factor 1: mechanisms and consequences. Biochem Pharmacol 59, 47-53.
65. Semenza GL (2000b). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88, 1474-1480.
66. Semenza GL (2001). Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7, 345-350.
67. 2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol 96, 1173-1177; discussion 1170-1172.
68. Semenza GL (2011). Oxygen sensing, homeostasis, and disease. N Engl J Med 365, 537-547.
69. Semenza GL (2014). Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 9, 47-71.
70. Semenza GL, Nejfelt MK, Chi SM & Antonarakis SE (1991). Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc Natl Acad Sci U S A 88, 5680-5684.
71. Shimoda LA, Fallon M, Pisarcik S, Wang J & Semenza GL (2006). HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol 291, L941-L949.
72. Shimoda LA, Manalo DJ, Sham JS, Semenza GL & Sylvester JT (2001). Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol Lung Cell Mol Physiol 281, L202-L208.
73. Smith TG, Balanos GM, Croft QP, Talbot NP, Dorrington KL, Ratcliffe PJ & Robbins PA (2008). The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 586, 5999-6005.
74. Smith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, Leon-Velarde F & Robbins PA (2009). Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 302, 1444-1450.
75. Stenmark KR, Fagan KA & Frid MG (2006). Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 99, 675-691.
76. +-ATPase function by hypoxia in rats. J Appl Physiol 87, 962-968.
77. Tan Q, Kerestes H, Percy MJ, Pietrofesa R, Chen L, Khurana TS, Christofidou-Solomidou M, Lappin TR & Lee FS (2013). Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation. J Biol Chem 288, 17134-17144.
78. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF & Tuder RM (2001). Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension. FASEB J 15, 427-438.
79. Tuder RM, Chacon M, Alger L, Wang J, Taraseviciene-Stewart L, Kasahara Y, Cool CD, Bishop AE, Geraci M, Semenza GL, Yacoub M, Polak JM & Voelkel NF (2001). Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195, 367-374.
80. Tuder RM, Flook BE & Voelkel NF (1995). Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95, 1798-1807.
81. Tuder RM, Yun JH, Bhunia A & Fijalkowska I (2007). Hypoxia and chronic lung disease. J Mol Med (Berl) 85, 1317-1324.
82. Veit F, Pak O, Egemnazarov B, Roth M, Kosanovic D, Seimetz M, Sommer N, Ghofrani HA, Seeger W, Grimminger F, Brandes RP, Schermuly RT & Weissmann N (2013). Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. Antioxid Redox Signal 19, 2213-2231.
83. Veith C, Marsh LM, Wygrecka M, Rutschmann K, Seeger W, Weissmann N & Kwapiszewska G (2012). Paxillin regulates pulmonary arterial smooth muscle cell function in pulmonary hypertension. Am J Pathol 181, 1621-1633.
84. Veith C, Schmitt S, Veit F, Dahal BK, Wilhelm J, Klepetko W, Marta G, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Fink L, Weissmann N & Kwapiszewska G (2013). Cofilin, a hypoxia-regulated protein in murine lungs identified by 2DE: role of the cytoskeletal protein cofilin in pulmonary hypertension. Proteomics 13, 75-88.
85. Veith C, Zakrzewicz D, Dahal BK, Balint Z, Murmann K, Wygrecka M, Seeger W, Schermuly RT, Weissmann N & Kwapiszewska G (2014). Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Thromb Haemost 112, 1288-1303.
86. 2 tension. Proc Natl Acad Sci USA 92, 5510-5514.
87. + channel alpha subunits in pulmonary artery smooth muscle cells. J Clin Invest 100, 2347-2353.
88. 2+ in pulmonary arterial smooth muscle cells. Circ Res 98, 1528-1537.
89. Ward JP (2006). Point: Hypoxic pulmonary vasoconstriction is mediated by increased production of reactive oxygen species. J Appl Physiol 101, 993-995; discussion 999.
90. 2 sensor? Respir Physiol Neurobiol 174, 201-211.
91. Weir EK & Archer SL (2006). Counterpoint: Hypoxic pulmonary vasoconstriction is not mediated by increased production of reactive oxygen species. J Appl Physiol 101, 995-998; discussion 998.
92. Weissmann N, Dietrich A, Fuchs B, Kalwa H, Ay M, Dumitrascu R, Olschewski A, Storch U, Mederos y Schnitzler M, Ghofrani HA, Schermuly RT, Pinkenburg O, Seeger W, Grimminger F & Gudermann T (2006). Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc Natl Acad Sci USA 103, 19093-19098.
93. Weissmann N, Sydykov A, Kalwa H, Storch U, Fuchs B, Mederos y Schnitzler M, Brandes RP, Grimminger F, Meissner M, Freichel M, Offermanns S, Veit F, Pak O, Krause KH, Schermuly RT, Brewer AC, Schmidt HH, Seeger W, Shah AM, Gudermann T, Ghofrani HA & Dietrich A (2012). Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice. Nat Commun 3, 649.
94. + channel expression in pulmonary arterial myocytes. Am J Physiol Lung Cell Mol Physiol 294, L309-L318.
95. Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, Bechmann I, Frei UA, Pugh CW, Ratcliffe PJ, Bachmann S, Maxwell PH & Eckardt KU (2003). Widespread hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs. FASEB J 17, 271-273.
96. Yoshida T, Zhang H, Iwase T, Shen J, Semenza GL & Campochiaro PA (2010). Digoxin inhibits retinal ischemia-induced HIF-1α expression and ocular neovascularization. FASEB J 24, 1759-1767.
97. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT & Semenza GL (1999). Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J Clin Invest 103, 691-696.
98. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R, Dang CV, Liu JO & Semenza GL (2008). Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth. Proc Natl Acad Sci USA 105, 19579-19586.
99. Zimnicka AM, Tang H, Guo Q, Kuhr FK, Oh MJ, Wan J, Chen J, Smith KA, Fraidenburg DR, Choudhury MS, Levitan I, Machado RF, Kaplan JH & Yuan JX (2014). Upregulated copper transporters in hypoxia-induced pulmonary hypertension. PLoS One 9, e90544.